# Study of Milnacipran for the Treatment of Fibromyalgia

> **NCT00098124** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 1200 (—)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** milnacipran hydrochloride

## Key facts

- **NCT ID:** NCT00098124
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 1200 (—)
- **Last updated:** 2007-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00098124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00098124, "Study of Milnacipran for the Treatment of Fibromyalgia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00098124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*